Literature DB >> 22843343

Pulmonary hypertension in an infant treated with ibuprofen.

Arvind Sehgal1, Prasanna S N Kumarshingri.   

Abstract

Presence of symptomatic patent ductus arteriosus is common in small preterm infants and ibuprofen is commonly used for its medical closure. While efficacy is comparable to indomethacin, there are few case reports of severe hypoxemia and pulmonary hypertension following prophylactic ibuprofen administration. Cumulative dose effects and chemical composition may be important considerations. Possible mechanisms of occurrence of this complication in a preterm infant are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843343     DOI: 10.1007/s12098-012-0829-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  6 in total

1.  Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach.

Authors:  Andra Malikiwi; Charlene Roufaeil; Kenneth Tan; Arvind Sehgal
Journal:  Eur J Pediatr       Date:  2014-10-26       Impact factor: 3.183

2.  Oral Paracetamol for Patent Ductus Arteriosus Rescue Closure.

Authors:  Pramod Pharande; Hadley Watson; Kenneth Tan; Arvind Sehgal
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

Review 3.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

4.  Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.

Authors:  Arne Ohlsson; Rajneesh Walia; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2020-02-11

Review 5.  Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.

Authors:  Arne Ohlsson; Rajneesh Walia; Sachin S Shah
Journal:  Cochrane Database Syst Rev       Date:  2018-09-28

6.  Timing of surgical ligation and morbidities in very low birth weight infants.

Authors:  YoungAh Youn; Cheong-Jun Moon; Jae-Young Lee; Cheul Lee; In Kyung Sung
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.